News...High-Tech Therapy Offers PD Patients Hope...Pramipexole (Mirapex) and more
 

Some items my require FREE registration to access the article.


USA / Science scores in 2010 US budget

Posted by Bob Grant
[Entry posted at 7th May 2009 10:29 PM GMT]

http://www.the-scientist.com/blog/display/55681/

Overall, federal science fares well in President Barack Obama's recently announced FY2010 budget, but the National Institutes of Health would net a pretty paltry increase under the president's plan. In the proposal, the NIH stands to get slightly more than $30.8 billion in 2010. This would represent a $443 million, or 1.5%, bump over the NIH's 2009 budget.


Neurology conference reports little progress in neurodegenerative disorders

Pharmaceutical Business Review, Published:08-May-2009, By Datamonitor staff writer
http://drugdiscovery.pharmaceutical-...sorders_080509
The neurodegenerative disease market saw few major announcements at this year's recent American Academy of Neurology conference. While the Alzheimer's disease field must wait until next year before efficacy data from late-stage pipeline drugs are released, Parkinson's disease announcements were restricted to post-marketing studies designed to reposition treatments or protect vulnerable franchises.


Brain protein central to both Parkinson's, drug addiction identified

Inovations Report, 07.05.2009, by nächste Meldung
http://www.innovations-report.de/htm...on_132173.html
Astrocytes come under scrutiny for yet another neurodegenerative disorder
Scientists have identified a protein that appears not only to be central to the process that causes Parkinson's disease but could also play a role in muting the high from methamphetamine and other addictive drugs.


AAN 2009: Pramipexole Effective in Reducing Depressive Symptoms in Parkinson's Disease

Medical News Today, by Caroline Cassels
http://www.medscape.com/viewarticle/702512

May 7, 2009 (Seattle, Washington) — Pramipexole (Mirapex, Boehringer Ingelheim) appears to be effective in treating depressive symptoms in patients with Parkinson's disease (PD), with a direct effect on depression that is not related to improvement of motor symptoms. A large multicenter, prospective, double-blind, placebo-controlled trial presented for the first time here at the American Academy of Neurology 61st Annual Meeting shows the dopamine agonist significantly reduced depressive symptoms compared with placebo in elderly PD patients with stable motor function.



Texas / High-Tech Therapy Offers Parkinson's Patients Hope
Interactive Video Games, Therapists Help Improve Motor Skills

KSAT, UPDATED: 12:19 pm CDT May 8, 2009
http://www.ksat.com/health/19407610/detail.html

SAN ANTONIO, TX -- A state-of-the-art facility is helping patients with Parkinson's Disease improve their motor skills. Warm Springs Rehabilitation Hospital offers high-tech therapy focused on improving the lives of Parkinson's patients.